The Voluntary Scheme for Branded Medicines Pricing, Access and Growth, or VPAG, was created to keep NHS costs down. Running ...

The British government is set to concede that the UK should pay more for some medicines, in an attempt to protect pharmaceutical exports to the US and arrest a wave of global drug companies pulling ...

Eli Lilly Chief Executive Dave Ricks said Britain was "probably the worst country in Europe" for drug prices in an interview ...

Science minister Lord Patrick Vallance has warned that the NHS will likely have to pay more for medicines to ensure the UK ...

Drug pricing talks between the U.K. government and pharmaceutical companies collapsed Friday, with industry leaders warning the standoff could deter investment. Health Secretary Wes Streeting ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The U.K. government is starting to recognize that the country ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Wes Streeting has walked away from acrimonious talks with pharmaceutical companies over drug pricing after the ...

NHS medicine prices "must increase to halt an exodus of pharmaceutical investment from Britain", the science minister has ...

Oct 22 (Reuters) - Britain's National Health Service (NHS) will block Eli Lilly's (LLY.N), opens new tab Alzheimer's drug donanemab on Wednesday, deeming it too expensive for NHS patients, the ...

Wes Streeting has promised not to allow pharmaceutical companies to "rip off" British taxpayers following failed talks over drug pricing with the firms. The Health Secretary's negotiations with the ...

The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%. Eli Lilly is increasing the price of Mounjaro, which is also used to treat type 2 diabetes, ...